BioFarma received support from the foundation to expand access to its novel oral poliovirus vaccine type 2 (nOPV2) for the Global Polio Eradication Initiative. Investment Date: April 2022
The foundation partnered with Sanofi to secure a reduced price for Inactivated Polio Vaccine (IPV).
Beijing Bio-Institute Biological Products is devoted to the research, development, production, and supply of biological products.
Sanofi Pasteur February 28, 2014 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today its further commitment to the international community’s efforts to complete polio eradication. UNICEF, the organization that procures the vaccine to meet Read More
Bill & Melinda Gates Foundation January 21, 2011 The Bill & Melinda Gates Foundation and UNICEF today announced that Mr. Anthony Lake, UNICEF Executive Director, and Dr. Tachi Yamada, president of the Global Health Program of the Gates Foundation, will Read More
Research in China November 16, 2011 Beijing Tiantan Biological Products (600161.SH) plans to sign financial aid, loan and unilateral guarantee agreements with the Bill & Melinda Gates Foundation to develop oral polio vaccines (OPV), reports stcn.com, citing a company filing. Read More